While the effect of GALNT7 and FAIM2 in tumor progression is known (the former favoring and the latter impairing tumor growth), their function in the context of skeletal muscle, exercise and contrast to sarcopenia is less obvious. The gene discussed is FAIM2; the disease is neoplasm.